BOCA RATON, Fla., Dec. 1, 2015 /PRNewswire/ -- Cancer Treatment Centers of America® (CTCA) is proud to announce the appointment of Dr. Robert (Rob) Hauser as the new vice president of clinical analytics at CTCA® Medicine & Science effective today. Dr. Hauser will work closely with the executive leadership teams of Medicine & Science, Information Services and the regional medical centers on the company's further development and implementation of an enterprise-wide clinical analytics strategy and program.
"Dr. Hauser's innovative leadership and unique skill set will enhance the CTCA mission of integrative and compassionate cancer care," said Dr. Maurie Markman, president of CTCA Medicine & Science. "Having clear and easily accessible clinical analytics is an essential part of our commitment to provide patient-focused coordinated care, particularly for those with more complex forms of cancer."
Dr. Hauser will direct the development of a robust analytics program to support enhancements in quality of care, clinical research and clinical innovation. In this role, he will assess the organization's clinical analytic and data needs, design strategy and tactics to meet those needs, and lead implementation of analytic and reporting strategies.
"I look forward to my new role at CTCA and the opportunity to build on the company's long-standing commitment to gather, analyze and present patient data in a manner that helps both patients and their physicians make more informed decisions about their care," said Dr. Hauser.
Dr. Hauser most recently served as senior director of the American Society of Clinical Oncology's (ASCO) Quality and Guidelines Department where he managed the development of ASCO's groundbreaking CancerLinQ project. Previously, he was the director of operations and informatics at the International Oncology Network. Additionally, Dr. Hauser also served as vice president and chief operating officer of Geriatric Oncology Consortium, Inc.
Dr. Hauser holds a doctor of pharmacy from The University of Texas at Austin/The University of Texas Health Science Center at San Antonio, and a doctorate in pharmacy practice and administration from The University of Texas at Austin.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America® (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-based complementary therapies that support patients physically and emotionally, enhancing their quality of life while reducing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.
SOURCE Cancer Treatment Centers of America